Interspond expedites the study start-up process for clinical drug studies.Interspond offers economies of scale with a solid industry reputation.Interspond has collectively met or exceeded enrollment goals 90% of the time.
Interspond works quickly to identify study opportunities for site participation.To the Interspond home page.About Interspond including background information on our expertise, case histories, clients and the therapuetic areas in which Interspond has worked.Services provided by Interspond for Sponsors & CRO's, and for Investigators and Sites.RxPaying™ is an exclusive service offered by Interspond, LLC that benefits CRO's, Sponsors, investigative Sites and Patients.How to contact Interspond, LLC for your next clincal study.

Interspond has over a decade of industry experience. Interspond accelerates the study start-up process.

Interspond expertise.

Interspond expertise.Interspond Case histories.Interspond client list.Therapeutic Areas.

Kathy S. Cox, MS - President & CEO

Kathy S. Cox, MS obtained her BSE from the University of Wisconsin - Whitewater in 1984 and her MS from the University of Wisconsin - LaCrosse in 1989. She has worked in the pharmaceutical research industry since 1989. She founded one of the original TMOs back in 1996. Since then she has continued to develop and fine tune this business model and has built it into what it is today. Interspond continues to thrive under her leadership and her thorough knowledge of this industry. Ms. Cox prides herself on Interspond's stellar reputation and the repeat business Interspond has enjoyed over the years.

Philip R. Billingsley, BA - Vice President

Philip R. Billingsley, BA joined the company as Sr. Director in 2007 and assumed the role of Vice President in 2008. He obtained his BA from the University of Washington in 1991. He has worked in corporate management for over a decade and served in a variety of capacities in marketing operations. Mr. Billingsley's focus will be on new product development with RxPaying™ being the first to launch.

Beth Biedenbender - Director of Business Development

Beth began in the industry in 1996 and has since propelled herself into a key position in the company. She now serves as Director of Business Development and is responsible for fostering and nurturing relationships with CROs and Sponsors. Beth has established an extensive network of contacts and continues to develop additional relationships with clients.
contact Interspond for your next drug or biotechnology study trial.



A trial management organization for the pharmaceutial and biotechnology industries.Interspond, LLC provides timely indentification of qualified investigative sites and expedites the study start-up process.A trial management organization for phase 1 through phase 4 studies.


© 2007 Interspond LLC - Verona, Wisconsin - (608) 541-8226